Clarissa Sifford, | |
1492 S Silicon Way, St George, UT 84770-7155 | |
(435) 275-8911 | |
Not Available |
Full Name | Clarissa Sifford |
---|---|
Gender | Female |
Speciality | Case Manager/care Coordinator |
Location | 1492 S Silicon Way, St George, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730539743 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Clarissa Sifford, 1492 S Silicon Way, St George, UT 84770-7155 Ph: (435) 275-8911 | Clarissa Sifford, 1492 S Silicon Way, St George, UT 84770-7155 Ph: (435) 275-8911 |
News Archive
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a strategic alliance with Boston Clinical Research Institute, an Academic Research Organisation based in Boston, Massachusetts.
A team of scientists, including faculty at the University of Massachusetts Medical School (UMMS), have discovered a gene that influences survival time in amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease).
Brainlab announced today that it has entered into a definitive agreement to acquire Voyant Health.
Results from a German national health survey indicate that asthma patients with multiple comorbidities are at increased risk for unplanned hospital admissions.
In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the way for the next 10 years of research on TB vaccines, a critical component of TB control efforts, note scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
› Verified 8 days ago